[FUNDING NEWS] Israel-Based Endoron Medical Secures $10 Million in Series A Round funding

The $10 million Series A fundraising round for Endoron Medical, a medical technology firm that creates endograft stapling solutions for the endovascular repair of abdominal aortic aneurysms , has closed successfully. Sofinnova Partners led the round, while the European Innovation Council Fund made a sizable matching contribution.

The clinical validation of Endoron’s flagship product, the catheter-based EndoStapling solution Aortoseal, which is presently progressing through its approved Early Feasibility Study by the Investigational Device Exemption,is expected to be accelerated by this substantial infusion of funding.

Read also- Philippines-Based Packworks Raises Around $60 Million in Government Funding

Endoron Medical was founded in 2019 by a group of professionals with vast experience in the field and in entrepreneurship. Professor Ron Karmeli, a vascular surgeon of international fame, Ronit Harpaz, an Elite 8400 member and former CEO of Bendit Technologies, and Eyal Teichman, a mechanical engineer with more than thirty years of R&D expertise, make up the founding team.

Read also- Israel-Based Nagish Secures $11 Million in Series A Round Funding

The critical issues of sealing and securing endografts employed in minimally invasive AAA repairs—particularly in complex procedures—are addressed by endoron technology for the endovascular repair of AAAs.

“Sofinnova Partners are the go-to investors within medtech. They bring a wealth of operational experience working with high-growth companies like ours,” said Ronit Harpaz, co-founder and CEO of Endoron. “With their continued support, I am confident we will reach key clinical and regulatory milestones as we advance our EndoStapling technology towards the clinic. The EIC’s participation further solidifies our commitment to bringing this innovative solution to the European market.”